HIF1A and cancer: Since Se is part of the mammalian physiology, it is relatively well tolerated and affects multiple upstream targets such as HIF-1α, Cox-2, and iNos [26] important for cancer survival and progression and is likely to have a better success as an antiangiogenic agent in combination chemotherapy [27].